Simply wow

Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2032183#.YCRhRVYGIoM.twitter
Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM

Original Article from The New England Journal of Medicine — Once-Weekly Semaglutide in Adults with Overweight or Obesity

https://www.nejm.org/doi/full/10.1056/NEJMoa2032183#.YCRhRVYGIoM.twitter
This is pretty freaking remarkable
It is not surprising that there were some significant GI side effects
Hard disagree with this from the editorial https://www.nejm.org/doi/full/10.1056/NEJMe2101705
Want to point out to those wondering about the nausea as being the “entire effect”. 17% of participants had nausea and 86% of people in sema arm had 5% or greater weight loss so nausea most definitely does not explain all of it. And the 86%, 5% or greater is stunning
I made a dumb mistake and misread that table. It was 17% nausea in placebo and 44% in sema arm. Still point stands that 86% lost more than 5% BW so this is not "just nausea"
You can follow @ethanjweiss.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled:
Those who think consciousness raising & movement building are disconnected, or even a distraction from electoral politics have not paid attention to the history of social change.In this thread, we
Read more
The 2020s will be known as the Remote Work decadeA few predictions of what is likely to emerge[ a thread ] Third Space: Office and Working from Home will
Read more
1/29: Have you ever had a concept explained to you that helps frame complex issues you’ve been wrestling with and opens your eyes to new possibilities? A concept that I
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.